The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBAE Systems Regulatory News (BA.)

Share Price Information for BAE Systems (BA.)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,320.00
Bid: 1,322.50
Ask: 1,323.50
Change: -43.50 (-3.19%)
Spread: 1.00 (0.076%)
Open: 1,357.00
High: 1,358.00
Low: 1,290.00
Prev. Close: 1,320.00
BA. Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Share Buyback Programme

28 Jul 2022 07:30

RNS Number : 9958T
BAE SYSTEMS PLC
28 July 2022
 

 

BAE Systems plc

 

Share Buyback Programme

 

Today, BAE Systems plc ("BAE Systems", or the "Company") announced its interim results for the half year ending 30 June 2022 and a share buyback programme (the "Buyback Programme") of up to £1.5 billion.

 

The Buyback Programme is consistent with the Company's disciplined approach to capital allocation, reflecting the Company's strong cash flow delivery and balance sheet position. The sole purpose of the Buyback Programme is to reduce the issued share capital of the Company.

 

Details of the Buyback Programme

 

The Company has entered into an arrangement with Morgan Stanley & Co. International plc ("Morgan Stanley") in relation to the purchase by Morgan Stanley, as riskless principal, of ordinary shares of BAE Systems (the "Shares"). This agreement relates to the first tranche of the Buyback Programme and is for an amount of up to £500 million ("First Tranche"). The First Tranche will run from and including 28 July 2022 and is expected to be completed by 30 June 2023.

 

Any purchases of Shares under the First Tranche will be effected within certain pre-set parameters. These arrangements are in accordance with BAE Systems' general authority to repurchase Shares granted at its Annual General Meeting held on 5 May 2022 (the "2022 AGM"), Chapter 12 of the Listing Rules, and those provisions of Article 5(1) of Regulation (EU) No. 596/2014 (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018) and the Commission Delegated Regulation (EU) 2016/1052 (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018) dealing with buyback programmes. The number of ordinary shares to be purchased under the Buyback Programme will not exceed 314,658,597 Shares and is therefore within the 2022 AGM approved limit.

 

Details of the authority granted at the 2022 AGM can be found on our website under: https://investors.baesystems.com/~/media/Files/B/Bae-Systems-Investor-Relations-V3/PDFs/results-and-reports/results/2022/agm-notice-of-meeting-2022.pdf  

 

 

For further information, please contact:

Investors

Media

Martin Cooper,

Investor Relations Director

Telephone: +44 (0)1252 383455

Email: investors@baesystems.com

Kristina Anderson,

Director, Media Relations

Telephone: +44 (0) 7540 628673

Email: Kristina.anderson@baesystems.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSPPUQUMUPPGRM
Date   Source Headline
25th Apr 20246:17 pmRNSTransaction in Own Shares
24th Apr 20246:06 pmRNSTransaction in Own Shares
23rd Apr 20245:43 pmRNSTransaction in Own Shares
22nd Apr 20245:25 pmRNSTransaction in Own Shares
19th Apr 20245:23 pmRNSTransaction in Own Shares
18th Apr 20246:22 pmRNSTransaction in Own Shares
18th Apr 20244:48 pmRNSDirector/PDMR Shareholding
17th Apr 20245:38 pmRNSTransaction in Own Shares
17th Apr 20241:39 pmRNSDirector/PDMR Shareholding
16th Apr 20246:01 pmRNSTransaction in Own Shares
15th Apr 20245:26 pmRNSTransaction in Own Shares
12th Apr 20245:16 pmRNSTransaction in Own Shares
11th Apr 20246:30 pmRNSTransaction in Own Shares
11th Apr 202411:15 amRNSDoc re: AGM documents
10th Apr 20246:05 pmRNSTransaction in Own Shares
9th Apr 20246:23 pmRNSTransaction in Own Shares
8th Apr 20246:14 pmRNSTransaction in Own Shares
5th Apr 20241:04 pmRNSDirector/PDMR Shareholding
4th Apr 20245:23 pmRNSTransaction in Own Shares
3rd Apr 20245:09 pmRNSTransaction in Own Shares
3rd Apr 20244:30 pmRNSDirector/PDMR Shareholding
2nd Apr 20245:41 pmRNSTransaction in Own Shares
28th Mar 20246:01 pmRNSTransaction in Own Shares
28th Mar 20244:38 pmRNSDirector/PDMR Shareholding
28th Mar 202411:25 amRNSDirector Declaration
28th Mar 202410:50 amRNSTotal Voting Rights
27th Mar 20245:25 pmRNSTransaction in Own Shares
26th Mar 20245:04 pmRNSTransaction in Own Shares
25th Mar 20245:14 pmRNSTransaction in Own Shares
22nd Mar 20245:33 pmRNSTransaction in Own Shares
21st Mar 20246:22 pmRNSTransaction in Own Shares
21st Mar 20242:03 pmRNSDirector/PDMR Shareholding
20th Mar 20245:52 pmRNSTransaction in Own Shares
20th Mar 202412:22 pmRNSDirector/PDMR Shareholding
20th Mar 20249:15 amRNSNotes Issuance
19th Mar 20245:43 pmRNSTransaction in Own Shares
18th Mar 20245:46 pmRNSTransaction in Own Shares
15th Mar 20245:50 pmRNSTransaction in Own Shares
15th Mar 202412:31 pmRNSDirector/PDMR Shareholding
14th Mar 20246:11 pmRNSTransaction in Own Shares
13th Mar 20245:20 pmRNSTransaction in Own Shares
12th Mar 20245:06 pmRNSTransaction in Own Shares
11th Mar 20246:26 pmRNSTransaction in Own Shares
11th Mar 202412:30 pmRNSDirector/PDMR Shareholding
8th Mar 20245:26 pmRNSTransaction in Own Shares
7th Mar 20246:21 pmRNSTransaction in Own Shares
7th Mar 20249:00 amRNSPublication of 2023 Annual Report
6th Mar 20245:10 pmRNSTransaction in Own Shares
5th Mar 20246:06 pmRNSTransaction in Own Shares
5th Mar 20242:32 pmRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.